// STATE LEGISLATION TRACKER

Ohio HB 253: License advanced practice respiratory therapists

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Passed chamber

State: Ohio
Bill: HB 253
Session: 136
Filed: 2025-04-30
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Ohio HB253 creates a new license for advanced practice respiratory therapists and lets them provide physician-supervised cardiopulmonary care. Based on the title, subjects, and available summaries, it does not directly target compounded peptides, off-label peptide prescribing, telehealth, naturopaths, NPs, or FDA 503A/503B compounding.

Key Points

No direct change to peptide access is apparent from the bill title or summary.
The bill is about respiratory therapist licensing, not peptide clinics or pharmacies.
It may create a narrow new prescriber category under physician supervision.
No clear impact on naturopathic or NP peptide prescribing is shown.
No clear change to 503A or 503B peptide compounding is shown.

What to Watch For

Note Watch whether amendments add broader prescribing rules beyond respiratory care.

Note Controlled-substance code sections are listed, but no peptide-specific effect is apparent from the summary.

✓

Opportunity If enacted, APRTs may gain limited prescribing authority for respiratory care under physician supervision.

Where the Bill Stands

The bill has passed the Ohio House and is now in the Senate committee process.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws